Kezar Life Sciences | 8-K: Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
Kezar Life Sciences | DEF 14A: Definitive information statements
Kezar Life Sciences | DEFA14A: Others
Kezar Life Sciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Kezar Life Sciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Kezar Life Sciences | 8-K: Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
Kezar Life Sciences | 8-K: Current report
Kezar Life Sciences | 8-K: Current report
Kezar Life Sciences | 8-K: Kezar Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
Kezar Life Sciences | 8-K: Current report
Kezar Life Sciences | 8-K: Current report
Kezar Life Sciences | 8-K: Current report
Kezar Life Sciences | 8-K: Current report
Kezar Life Sciences | 8-K: Kezar Life Sciences Reports Second Quarter 2023 Financial Results and Provides Business Update
Kezar Life Sciences | 8-K: Current report
Kezar Life Sciences | 8-K: Current report
Kezar Life Sciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Kezar Life Sciences | 8-K: Kezar Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update
Kezar Life Sciences | 8-K: Current report
Kezar Life Sciences | DEFA14A: Others
No Data